Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Completed · Phase 2 · Has a placebo group
Conditions studied: Skin Carcinoma
In brief
RATIONALE: Drugs used in chemotherapy, such as tazarotene, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This randomized phase II trial is comparing two different schedules of topical tazarotene and topical placebo to see how well they work in treating patients with basal cell skin cancer and basal cell nevus syndrome on the chest.
Key facts
- Study ID
- NCT00783965
- Run by
- UCSF Benioff Children's Hospital Oakland
- People needed
- 34
- Starts
- 2004-07-01
- Expected to finish
- 2014-01-01
- Last updated by the study team
- 2016-02-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Children's Hospital Oakland Research Institute — Oakland, California, United States
- Children's Hospital Oakland Research Institiute — Oakland, California, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.